{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Pathogenic mutations in LRRK2 (e.g., G2019S) associated with increased kinase activity"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0002309"
  },
  "Experiment Method": [
    {
      "Assay Method": "Protein Expression and Inclusion Body Analysis",
      "Material used": {
        "Material Source": "Neuronal cell lines and human midbrain neurons",
        "Material Name": "Neuronal cell lines (e.g., SH-SY5Y) and primary human midbrain neurons",
        "Description": "Neurons and neuronal cell lines were used to study the effects of mutant dardarin (LRRK2) expression."
      },
      "Readout type": "Qualitative (inclusion body formation) and Quantitative (cell death assays)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (increased kinase activity) in pathogenic mutants",
          "Result Description": "Expression of pathogenic LRRK2 mutants led to increased inclusion body formation and neuronal cell death."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 expression served as a positive control for normal kinase activity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Kinase-dead LRRK2 (Fkinase-dead) mutant served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": 2
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": 1
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Absence of inclusion bodies and <10% cell death",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of inclusion bodies and >30% cell death",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}